Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Leukemia
-
Cancer related to blood cells is called as Leukemia. Under Leukemia condition, bone marrow produces abnormal cancerous blood cells that crowd out the normal and healthy blood cells. Leukemia is of different types based which blood cell type has become cancerous. White blood cells are more to prone to become cancerous than RBCs and platelets. Leukemia can be acute or chronic and Lymphocytic or Myelogenous. It occurs most commonly in adults above 55 years and children younger than 15 years. The treatment methods used depend on the blood cell affected and whether the leukemia is acute or chronic or Lymphocytic or Myelogenous. Chemotherapy is frequently used to treat leukemia.
-
Chronic Lymphocytic Leukaemia (CLL) is the most common form of leukaemia in the Western world, with an incidence that in Italy is estimated at between 5.0 and 5.5 cases per 100,000 men and between 3.5 and 4.0 cases every 100,000 women.
Speaker PPTs
- Anne Stinn
Deciphering the crystal structure of NF-CU - a novel bispecific antibody for the treatment of acute myeloid leukemia
PPT Version | PDF Version - C Cameron Yin
Role of Immunoglobulin Gene Expression in Acute Myeloid Leukemia
PPT Version | PDF Version - Barbara Klajnert-Maculewicz
Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
PPT Version | PDF Version - Justyna Trynda
The role of microRNA-125b in calcitriol-induced differentiation of human leukemia and lymphoma cells
PPT Version | PDF Version - Soo-Young Yoon
Isocitrate dehydrogenase 1 (IDH1) mutation-specific twelve microRNA signatures as prognostic biomarkers in acute myeloid leukemia
PPT Version | PDF Version - Jackleen Raafat
Expression of CD95 in Acute Lymphocytic Leukemia (ALL) in Egyptian Children before and after Treatment
PPT Version | PDF Version - Xiayuan Liang
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathological Variations in Childhood B-Lymphoblastic Leukemia
PPT Version | PDF Version - Emmanuel C. Besa
New opportunities in a personalized approach to the preleukemic phase of myelodysplastic syndrome and acute myelogenous leukemia
PPT Version | PDF Version - Tereza Jancuskova
A novel approach for unique MRD markers identification in acute leukemia patients
PPT Version | PDF Version